News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
239,559 Results
Type
Article (13587)
Company Profile (41)
Press Release (225931)
Multimedia
Podcasts (29)
Webinars (8)
Section
Business (79646)
Career Advice (740)
Deals (14002)
Drug Delivery (27)
Drug Development (28766)
Employer Resources (60)
FDA (5243)
Job Trends (5173)
News (115915)
Policy (9916)
Tag
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (1)
2027 Pharm Country Standard (1)
Academia (1183)
Academic (1)
Accelerated approval (16)
ADA (13)
Allergies (84)
Alliances (21296)
ALS (98)
Alzheimer's disease (729)
Antibody-drug conjugate (ADC) (288)
Approvals (5610)
Artificial intelligence (346)
ASCO (119)
Autoimmune disease (173)
Automation (24)
Bankruptcy (61)
Best Places to Work (4293)
BIO (34)
BIOSECURE Act (3)
Biosimilars (142)
BioSpace Insights (48)
Biotechnology (30)
Bladder cancer (73)
Brain cancer (31)
Breast cancer (306)
Cancer (2603)
Cardiovascular disease (178)
Career advice (638)
Career pathing (18)
CAR-T (141)
CDC (12)
Cell therapy (401)
Cervical cancer (26)
Clinical research (25149)
Collaboration (1237)
Commercialization (3)
Company closure (4)
Compensation (203)
Complete response letters (15)
COVID-19 (2051)
CRISPR (63)
C-suite (603)
Cystic fibrosis (63)
Data (3549)
Decentralized trials (1)
Denatured (20)
Depression (69)
Dermatology (59)
Diabetes (177)
Diagnostics (2854)
Digital health (28)
Diversity (7)
Diversity, equity & inclusion (15)
Drug discovery (222)
Drug pricing (38)
Drug shortages (1)
Duchenne muscular dystrophy (125)
Earnings (21326)
Editorial (13)
Employer branding (7)
Employer resources (61)
Events (32121)
Executive appointments (528)
FDA (6811)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (13)
Frontotemporal dementia (16)
Funding (1047)
Gene editing (135)
Generative AI (28)
Gene therapy (255)
GLP-1 (366)
Government (1457)
Grass and pollen (4)
Guidances (143)
Healthcare (6146)
Hematology (73)
HIV (46)
Huntington's disease (20)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (62)
Immunology and inflammation (115)
Immuno-oncology (58)
Indications (90)
Infectious disease (2190)
Inflammatory bowel disease (93)
Inflation Reduction Act (7)
Influenza (74)
Intellectual property (141)
Interviews (134)
IPO (6796)
IRA (14)
Job creations (1056)
Job search strategy (509)
JPM (16)
Kidney cancer (15)
Labor market (34)
Layoffs (137)
Leadership (23)
Legal (2217)
Licensing (5)
Liver cancer (42)
Longevity (18)
Lung cancer (326)
Lymphoma (206)
Machine learning (22)
Management (25)
Manufacturing (407)
Marketing (4)
MASH (69)
Medical device (4076)
Medtech (4137)
Mergers & acquisitions (7926)
Metabolic disorders (490)
mRNA (115)
Multiple sclerosis (75)
NASH (1)
Neurodegenerative disease (190)
Neuropsychiatric disorders (38)
Neuroscience (1390)
NextGen: Class of 2026 (2083)
Non-profit (1396)
Now hiring (17)
Obesity (225)
Opinion (82)
Ovarian cancer (106)
Pain (98)
Pancreatic cancer (129)
Parkinson's disease (179)
Partnered (13)
Patents (232)
Patient recruitment (324)
Peanut (17)
People (24216)
Pharmaceutical (8)
Pharmacy benefit managers (9)
Phase 1 (7718)
Phase 2 (10779)
Phase 3 (9193)
Pipeline (4197)
Policy (65)
Postmarket research (808)
Preclinical (3231)
Press Release (20)
Prostate cancer (109)
Psychedelics (17)
Radiopharmaceuticals (103)
Rare diseases (393)
Real estate (1800)
Recruiting (26)
Regulatory (8367)
Reports (14)
Research institute (1083)
Resumes & cover letters (93)
Rett syndrome (10)
RNA editing (12)
RSV (30)
Schizophrenia (64)
Series A (239)
Series B (174)
Service/supplier (2)
Sickle cell disease (22)
Special edition (6)
Spinal muscular atrophy (32)
Sponsored (13)
Startups (2033)
Stomach cancer (5)
Supply chain (39)
Tariffs (6)
The Weekly (9)
Vaccines (539)
Venture capital (55)
Weight loss (97)
Women's health (76)
Worklife (14)
Date
Last 7 days (240)
Last 30 days (809)
Last 365 days (11007)
2026 (6804)
2025 (10746)
2024 (12551)
2023 (14605)
2022 (21034)
2021 (23174)
2020 (21963)
2019 (15266)
2018 (11531)
2017 (11189)
2016 (10248)
2015 (12327)
2014 (9023)
2013 (7258)
2012 (7580)
2011 (7764)
2010 (6689)
Location
Africa (277)
Alabama (40)
Alaska (4)
Arizona (87)
Arkansas (5)
Asia (29112)
Australia (3668)
California (5629)
Canada (1439)
China (886)
Colorado (283)
Connecticut (215)
Delaware (158)
Europe (35665)
Florida (583)
Georgia (81)
Hawaii (4)
Idaho (24)
Illinois (298)
India (69)
Indiana (182)
Iowa (8)
Japan (458)
Kansas (41)
Kentucky (9)
Louisiana (15)
Maine (13)
Maryland (484)
Massachusetts (3592)
Michigan (59)
Minnesota (201)
Mississippi (5)
Missouri (33)
Montana (7)
Nebraska (6)
Nevada (41)
New Hampshire (27)
New Jersey (1482)
New Mexico (8)
New York (1332)
North Carolina (547)
North Dakota (5)
Northern California (2956)
Ohio (165)
Oklahoma (11)
Oregon (21)
Pennsylvania (855)
Puerto Rico (6)
Rhode Island (17)
South America (308)
South Carolina (10)
South Dakota (1)
Southern California (2163)
Tennessee (48)
Texas (614)
United States (17326)
Utah (144)
Vermont (2)
Virginia (148)
Washington D.C. (31)
Washington State (422)
West Virginia (2)
Wisconsin (59)
239,559 Results for "transthera biosciences co ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Visionary Holdings’ Subsidiary Nanjing Tuoyuanjian Health Technology Co., Ltd. Enters into Distribution Agreement with Suncare (Shanghai) Health Technology Co., Ltd.
Collaboration Expected to Expand the Commercialization of Stem Cell Aesthetic and Anti-Aging Products Through an AI-Enabled Community Healthcare and Senior Care Network in China
July 29, 2026
·
4 min read
Immunology and inflammation
Neurocrine Goes to China To Grow Pipeline in up to $881M TransThera Deal
At the center of the licensing deal is an NLRP3 inhibitor that has shown “encouraging efficacy in acute inflammation models,” according to TransThera, indicating its potential in various metabolic and inflammatory diseases.
November 3, 2025
·
1 min read
·
Dan Samorodnitsky
Press Releases
Andelyn Biosciences and ENCell Co., Ltd Announce Strategic Partnership to Expand Global Reach of Gene Therapy Manufacturing
April 21, 2026
·
4 min read
Press Releases
Cellyan Biotechnology Co., Ltd Receives Nasdaq Notice of Additional Compliance Grace Period
July 17, 2026
·
4 min read
Press Releases
Shanghai Kinbio Tech Co., Ltd. Announces Strategic Expansion with New Kinbionova Showroom in San Diego
July 8, 2026
·
1 min read
Press Releases
TransThera Publishes Clinical Studies of Tinengotinib (TT-00420) against Cholangiocarcinoma on Lancet
December 5, 2025
·
3 min read
Press Releases
FreeMind Investments and Daewoong Pharmaceutical Co., Ltd. Invest in General Proximity
May 4, 2026
·
4 min read
Press Releases
Nielsen BioSciences Announces Expanded CANDIN License Agreement with Maruho Co. Ltd.
October 24, 2025
·
3 min read
Press Releases
ATM Equity Purchases by Pulse Biosciences’ Co-Chairmen Total Approximately $13.3 Million
May 12, 2026
·
1 min read
Mergers & acquisitions
Argenx deepens immuno expertise with $2.2B Forte Biosciences buy
The star of the takeover is Forte Biosciences’ investigational antibody therapy, FB102, which has shown early potential in vitiligo and celiac disease.
July 27, 2026
·
2 min read
·
Tristan Manalac
1 of 23,956
Next
